Showing results (841-850 of 1,170) with videos related to

Sort By:
Pageof 117
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|December 20, 2008
[Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection]Zheng-gang Ren, Yu-hong Gan, Jia Fan, et al.
Medicine|March 16, 2017
Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resectionChu-Yu Jing, Yi-Peng Fu, Su-Su Zheng, et al.
Cancer Journal (Sudbury, Mass.)|April 25, 2006
Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patientsZhao-Chong Zeng, Zhao-You Tang, Jia Fan, et al.
Plos One|May 2, 2013
Genetic polymorphism of the kinesin-like protein KIF1B gene and the risk of hepatocellular carcinomaZhi-Chao Wang, Qiang Gao, Jie-Yi Shi, et al.
Journal of Hematology & Oncology|February 28, 2018
NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cellsBo Hu, Guang-Yu Ding, Pei-Yao Fu, et al.
Nature Chemical Biology|February 10, 2019
Publisher Correction: N6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylationHonghui Ma, Xiaoyun Wang, Jiabin Cai, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 8, 2020
Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?Qiang Zhou, Hao Cai, Ming-Hao Xu, et al.
Nature Chemical Biology|December 12, 2018
N6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylationHonghui Ma, Xiaoyun Wang, Jiabin Cai, et al.
Journal of Translational Medicine|June 20, 2019
Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patientsGui-Qi Zhu, Yi Yang, Er-Bao Chen, et al.
Cancer Immunology Research|April 10, 2026
Tumor-infiltrating platelets recruit neutrophils to promote tumor growth through the 5-HIAA-GPR35-ERK1/2 axis in Hepatocellular CarcinomaNing Li, Peng-Cheng Wang, Jing-Yue Pan, et al.
Pageof 117